Ligand binding analysis for human α5β1 integrin: Strategies for designing new α5β1 integrin antagonists

Luciana Marinelli; Axel Meyer; Dominik Heckmann; Antonio Lavecchia; Ettore Novellino; Horst Kessler

doi:10.1021/jm040224i

Ligand binding analysis for human α5β1 integrin: Strategies for designing new α5β1 integrin antagonists

Luciana Marinelli
, Axel Meyer
, Dominik Heckmann
, Antonio Lavecchia
, Ettore Novellino
, Horst Kessler

TUM Emeriti of Excellence

Università degli Studi di Napoli Federico II
Technical University of Munich

Research output: Contribution to journal › Article › peer-review

69 Scopus citations

Abstract

We report a three-dimensional model of the α5β1 integrin headgroup bound to the most potent and selective ligand (SJ749) known to date. The model was built using the comparative protein modeling method, and it is consistent with experimental data. From this study, we identified two potentially important regions in the α5β1 receptor that are peculiar to this integrin and might be worth considering for drug targeting.

Original language	English
Pages (from-to)	4204-4207
Number of pages	4
Journal	Journal of Medicinal Chemistry
Volume	48
Issue number	13
DOIs	https://doi.org/10.1021/jm040224i
State	Published - 30 Jun 2005

Access to Document

10.1021/jm040224i

Cite this

@article{c77f4e7613204e06a3813c50d981a337,

title = "Ligand binding analysis for human α5β1 integrin: Strategies for designing new α5β1 integrin antagonists",

abstract = "We report a three-dimensional model of the α5β1 integrin headgroup bound to the most potent and selective ligand (SJ749) known to date. The model was built using the comparative protein modeling method, and it is consistent with experimental data. From this study, we identified two potentially important regions in the α5β1 receptor that are peculiar to this integrin and might be worth considering for drug targeting.",

author = "Luciana Marinelli and Axel Meyer and Dominik Heckmann and Antonio Lavecchia and Ettore Novellino and Horst Kessler",

year = "2005",

month = jun,

day = "30",

doi = "10.1021/jm040224i",

language = "English",

volume = "48",

pages = "4204--4207",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "13",

}

TY - JOUR

T1 - Ligand binding analysis for human α5β1 integrin

T2 - Strategies for designing new α5β1 integrin antagonists

AU - Marinelli, Luciana

AU - Meyer, Axel

AU - Heckmann, Dominik

AU - Lavecchia, Antonio

AU - Novellino, Ettore

AU - Kessler, Horst

PY - 2005/6/30

Y1 - 2005/6/30

N2 - We report a three-dimensional model of the α5β1 integrin headgroup bound to the most potent and selective ligand (SJ749) known to date. The model was built using the comparative protein modeling method, and it is consistent with experimental data. From this study, we identified two potentially important regions in the α5β1 receptor that are peculiar to this integrin and might be worth considering for drug targeting.

AB - We report a three-dimensional model of the α5β1 integrin headgroup bound to the most potent and selective ligand (SJ749) known to date. The model was built using the comparative protein modeling method, and it is consistent with experimental data. From this study, we identified two potentially important regions in the α5β1 receptor that are peculiar to this integrin and might be worth considering for drug targeting.

UR - https://www.scopus.com/pages/publications/21244467582

U2 - 10.1021/jm040224i

DO - 10.1021/jm040224i

M3 - Article

C2 - 15974570

AN - SCOPUS:21244467582

SN - 0022-2623

VL - 48

SP - 4204

EP - 4207

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 13

ER -

Ligand binding analysis for human α5β1 integrin: Strategies for designing new α5β1 integrin antagonists

Abstract

Access to Document

Other files and links

Fingerprint

Cite this